VIRX

Viracta Therapeutics, Inc.

OTCHealthcareBiotechnologyUS

USD0.01

+0.00 (+0.00%)

CEO

Craig R. Jalbert

IPO Date

2005-09-27

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

Country

Open

$0.01

Prev. Close

$0.01

Day Low

$0.01

Day High

$0.01

52W Low

$0.01

52W High

$0.19

Market Cap

$0.00B

News SentimentBullish

Articles

Avg Positive

47.5%

Avg Negative

1.0%

Avg Neutral

51.0%

News Feed

Viracta Therapeutics Announces FDA Clearance of IND Application for Phase 1b/2 Trial in Epstein-Barr Virus-Positive (EBV+) Solid Tumors

Viracta Therapeutics Announces its Addition to the Russell 2000® Index and other FTSE Russell Indexes

Viracta Therapeutics to Host Key Opinion Leader Webinar